| FGF21 gene therapy as treatment for obesity and insulin resistance V Jimenez, C Jambrina, E Casana, V Sacristan, S Muñoz, S Darriba, ... EMBO molecular medicine 10 (8), e8791, 2018 | 224 | 2018 |
| Vitamin D receptor overexpression in β-cells ameliorates diabetes in mice M Morró, L Vilà, S Franckhauser, C Mallol, G Elias, T Ferré, M Molas, ... Diabetes 69 (5), 927-939, 2020 | 42 | 2020 |
| Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: 8-year follow-up in dogs ML Jaén, L Vilà, I Elias, V Jimenez, J Rodó, L Maggioni, ... Molecular Therapy Methods & Clinical Development 6, 1-7, 2017 | 41 | 2017 |
| BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice E Casana, V Jimenez, V Sacristan, S Muñoz, C Jambrina, J Rodó, ... International Journal of Obesity 45 (2), 449-460, 2021 | 14 | 2021 |
| FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med 10 (8): e8791 V Jimenez, C Jambrina, E Casana, V Sacristan, S Muñoz, S Darriba, ... | 11 | 2018 |
| AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity E Casana, V Jimenez, C Jambrina, V Sacristan, S Muñoz, J Rodo, I Grass, ... Molecular Therapy-Methods & Clinical Development 25, 190-204, 2022 | 8 | 2022 |
| FRET-based screening identifies p38 MAPK and PKC inhibition as targets for prevention of seeded α-synuclein aggregation A Svanbergsson, F Ek, I Martinsson, J Rodo, D Liu, E Brandi, C Haikal, ... Neurotherapeutics 18 (3), 1692-1709, 2021 | 7 | 2021 |
| FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med. 2018; 10 V Jimenez, C Jambrina, E Casana, V Sacristan, S Muñoz, S Darriba, ... | 4 | |
| Integrated gene expression profiles reveal a transcriptomic network underlying the thermogenic response in adipose tissue J Rodó, M Garcia, E Casana, S Muñoz, C Jambrina, V Sacristan, ... Scientific reports 13 (1), 7266, 2023 | 2 | 2023 |
| FRET-based screening in HEK293T identifies p38 MAPK and PKC inhibition as therapeutic targets for α-synuclein aggregation A Svanbergsson, F Ek, I Martinsson, J Rodo, D Liu, E Brandi, C Haikal, ... bioRxiv, 2021.02. 16.431382, 2021 | 1 | 2021 |
| Transcriptomic analysis of white and brown adipose tissue during non-shivering thermogenesis J Rodó Morera | 1 | 2019 |
| Long-term correction of diabetes in dogs after single intramuscular administration of adeno-associated viral vectors encoding for insulin and glucokinase V Haurigot, ML Jaén, J Rodó, L Vilà, M Garcia, I Elias, L Maggioni, X Leon, ... New Biotechnology, S11, 2016 | 1 | 2016 |
| AAV-Mediated BMP7 Gene Therapy Counteracts Insulin Resistance and Obesity M Garcia, E Casana, V Jimenez, C Jambrina, V Sacristan, S Munoz, ... MOLECULAR THERAPY 30 (4), 473-473, 2022 | | 2022 |
| Development of an iLite (R) Reporter Cell Platform for the Quantification of Anti-AAV Neutralizing Antibodies J Rodo, LF Bovin, B Vallette, S Broselid, M Schwenkert, C Lallemand, ... MOLECULAR THERAPY 30 (4), 527-527, 2022 | | 2022 |
| Characterization of a reporter gene cell line for the easy assessment of therapeutic AAV vectors-a case study J Rodo, S Broselid, T Segerstein HUMAN GENE THERAPY 32 (19-20), A30-A30, 2021 | | 2021 |
| FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation JYL Alexander Svanbergsson, Fredrik Ek, Isak Martinsson, Jordi Rodó, Di Liu ... https://link.springer.com/article/10.1007%2Fs13311-021-01070-1, 2021 | | 2021 |
| Skeletal muscle-directed FGF21 gene therapy counteracts obesity and type 2 diabetes C Jambrina, V Sacristan, E Casana, S Munoz, J Rodo, L Vila, M Garcia, ... HUMAN GENE THERAPY 30 (11), A152-A152, 2019 | | 2019 |
| AAV-FGF21 gene therapy mediates healthspan expansion in old mice V Sacristan, C Jambrina, J Rodo, M Garcia, E Casana, S Munoz, L Vila, ... HUMAN GENE THERAPY 30 (11), A15-A15, 2019 | | 2019 |
| Healthspan expansion in old mice by an AAV-mediated FGF21 gene therapy C Jambrina, V Sacristan, J Rodo, M Garcia, E Casana, S Munoz, ... DIABETOLOGIA 62, S293-S293, 2019 | | 2019 |
| Skeletal Muscle-Directed FGF21 Gene Therapy Counteracts Obesity and Type 2 Diabetes F Bosch, C Jambrina, V Sacristan, E Casana, S Munoz, J Rodo, S Darriba, ... MOLECULAR THERAPY 27 (4), 369-369, 2019 | | 2019 |
